Rocephin and Hydrea drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Rocephin (ceftriaxone sodium) and Hydrea (hydroxyurea). Common drug interactions include influenza among females and coma among males.

The phase IV clinical study analyzes what interactions people have when they take Rocephin and Hydrea. It is created by eHealthMe based on reports of 35 people who take the same drugs from the FDA, and is updated regularly.

What is Rocephin?

Rocephin has active ingredients of ceftriaxone sodium. It is often used in infection. eHealthMe is studying from 15,665 Rocephin users. Check the latest studies of Rocephin.

What is Hydrea?

Hydrea has active ingredients of hydroxyurea. It is often used in polycythemia vera. eHealthMe is studying from 9,083 Hydrea users. Check the latest studies of Hydrea.



On Jul, 14, 2026

35 people who take Rocephin and Hydrea together, and have interactions are studied.

Rocephin and Hydrea drug interactions.

What are the common drug interactions of Rocephin and Hydrea, by gender? *:

female:

  1. Influenza
  2. Infusion site haemorrhage (bleeding from infusion site)
  3. International normalised ratio increased
  4. Muscle spasms (muscle contraction)
  5. Oedema peripheral (superficial swelling)
  6. Pain
  7. Pain in extremity
  8. Pain in jaw
  9. Pulmonary hypertension (increase in blood pressure in the lung artery)
  10. Red blood cell count decreased

male:

  1. Coma (state of unconsciousness lasting more than six hours)
  2. Hallucination, auditory (perceiving sounds without auditory stimulus)
  3. Sinus bradycardia (an unusually slow heartbeat due to heart disease)
  4. Cardiac failure congestive
  5. Haemoglobin decreased
  6. Sinus arrhythmia (a naturally occurring variation in heart rate that occurs during a breathing cycle)
  7. Thrombocytopenia (decrease of platelets in blood)
  8. Headache (pain in head)
  9. Activated partial thromboplastin time prolonged
  10. Acute respiratory failure

What are the common drug interactions of Rocephin and Hydrea, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Back pain
  2. Pyrexia (fever)

10-19:

  1. Pyrexia (fever)
  2. Cytolytic hepatitis (dissolution or destruction of a liver cell)
  3. Hepatomegaly (abnormal enlargement of the liver)
  4. Jaundice cholestatic
  5. Pancreatitis (inflammation of pancreas)
  6. Campylobacter infection (infection by the campylobacter bacterium)
  7. Hepatic pain (pain in liver)
  8. Abdominal pain
  9. Hepatic enzyme increased
  10. Liver disorder (liver diseases)

20-29:

  1. Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
  2. Rash maculo-papular (red area on the skin that is covered with small confluent bumps)
  3. Alanine aminotransferase increased
  4. Aspartate aminotransferase increased
  5. Haemolysis (breaking open of red blood cells and the release of haemoglobin into the surrounding fluid)
  6. Hyperbilirubinaemia (excess of bilirubin in the blood)
  7. Acute respiratory failure
  8. Brain abscess
  9. Brain oedema (excess accumulation of fluid in the intracellular or extracellular spaces of the brain)
  10. Cerebral haemorrhage (bleeding within the brain)

30-39:

  1. Coma (state of unconsciousness lasting more than six hours)
  2. Hallucination, auditory (perceiving sounds without auditory stimulus)
  3. Hallucination, visual (seeing things that aren't there)
  4. Dermatitis exfoliative (widespread scaling of the skin, often with itching (pruritus), skin redness (erythroderma), and hair loss)
  5. Hallucination (an experience involving the perception of something not present)
  6. Palmar-plantar erythrodysaesthesia syndrome (hand-foot syndrome)
  7. Pyrexia (fever)
  8. Headache (pain in head)
  9. Cellulitis (infection under the skin)

40-49:

  1. Infusion site erythema (reddening of the skin at infusion site)
  2. Infusion site pain
  3. Insomnia (sleeplessness)
  4. International normalised ratio decreased
  5. Intra-abdominal haemorrhage (intra-abdominal bleeding)
  6. Malaise (a feeling of general discomfort or uneasiness)
  7. Memory impairment
  8. Oliguria (not enough urine)
  9. Pallor
  10. Pleural effusion (water on the lungs)

50-59:

  1. Abdominal pain
  2. Activated partial thromboplastin time prolonged
  3. Arthralgia (joint pain)
  4. Blood bilirubin increased
  5. Blood lactate dehydrogenase increased
  6. Cardiac failure congestive
  7. Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
  8. Fatigue (feeling of tiredness)
  9. Haemoglobin decreased
  10. Hepatic fibrosis (scarring process that represents the liver's response to injury)

60+:

  1. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  2. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  3. Nausea (feeling of having an urge to vomit)
  4. Pyelonephritis (inflammation of kidney caused by bacteria)
  5. Pyrexia (fever)
  6. Skin candida (fungal infection of skin)
  7. Abdominal pain
  8. Electrocardiogram qt prolonged
  9. Sinus bradycardia (an unusually slow heartbeat due to heart disease)
  10. Blood alkaline phosphatase increased

What are the existing conditions these people have? *

  1. Fever: 15 people, 42.86%
  2. Brain Abscess: 7 people, 20.00%
  3. Campylobacter Infection (infection by the campylobacter bacterium): 7 people, 20.00%
  4. Aspergillosis (an infection caused by a fungus called aspergillus): 6 people, 17.14%
  5. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 4 people, 11.43%
  6. Pneumonia: 3 people, 8.57%
  7. C-Reactive Protein Increased: 3 people, 8.57%
  8. Cardiac Failure: 3 people, 8.57%
  9. Clostridium Difficile Colitis (inflammation of colon by clostridium difficile bacteria infection): 3 people, 8.57%
  10. Pulmonary Hypertension (increase in blood pressure in the lung artery): 3 people, 8.57%

* Approximation only. Some reports may have incomplete information.

Do you take Rocephin and Hydrea?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Rocephin and Hydrea:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Rocephin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Hydrea:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Rocephin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Hydrea and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on ceftriaxone sodium and hydroxyurea (the active ingredients of Rocephin and Hydrea, respectively), and Rocephin and Hydrea (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: